Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Leases (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 9 years of Leases data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Leases rose 9.8% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, up 9.8%, while the annual FY2025 figure was $2.4 million, 9.8% up from the prior year.
  • Leases reached $2.4 million in Q4 2025 per VRDN's latest filing, up from $700000.0 in the prior quarter.
  • Across five years, Leases topped out at $2.4 million in Q4 2025 and bottomed at $500000.0 in Q3 2024.
  • Average Leases over 5 years is $1.6 million, with a median of $1.6 million recorded in 2021.
  • Peak YoY movement for Leases: skyrocketed 501.5% in 2021, then crashed 73.05% in 2024.
  • A 5-year view of Leases shows it stood at $1.7 million in 2021, then dropped by 4.17% to $1.6 million in 2022, then rose by 3.73% to $1.7 million in 2023, then soared by 32.04% to $2.2 million in 2024, then rose by 9.8% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $2.4 million in Q4 2025, $700000.0 in Q3 2025, and $2.0 million in Q2 2025.